臨床藥理學與治療學(CPT)是實驗醫(yī)學和臨床醫(yī)學的權威交叉學科期刊，致力于發(fā)表治療學的性質、作用、療效和評價方面的進展。CPT歡迎翻譯、預測和個性化醫(yī)學新興領域的原創(chuàng)文章、信函和通信;新的治療方式包括基因和細胞療法;藥物基因組學、蛋白質組學和代謝組學;生物信息和應用系統(tǒng)生物學補充藥物動力學和藥效學、人體調查和臨床試驗、藥物警戒、藥物流行病學、藥物計量學和人口藥理學等領域。評論和觀點對位提供了一個論壇的觀點，臨床藥理學和治療在當代科學，政治，經(jīng)濟和社會問題的背景下。《最新進展》綜述了支持藥物發(fā)現(xiàn)、開發(fā)、管理和利用的科學方面的最新進展。CPT強調轉變臨床藥理學實踐的問題，包括倫理、教育和公共政策。在臨床應用的基礎藥理學，發(fā)現(xiàn)和翻譯醫(yī)學，以及藥物開發(fā)的背景下，治療的基準到床邊翻譯。

Clinical Pharmacology & Therapeutics (CPT) is the authoritative cross-disciplinary journal in experimental and clinical medicine devoted to publishing advances in the nature, action, efficacy, and evaluation of therapeutics. CPT welcomes original articles, letters and communications in the emerging areas of translational, predictive and personalized medicine; new therapeutic modalities including gene and cell therapies; pharmacogenomics, proteomics and metabolomics; bioinformation and applied systems biology complementing areas of pharmacokinetics and pharmacodynamics, human investigation and clinical trials, pharmacovigilence, pharmacoepidemiology, pharmacometrics, and population pharmacology. Commentaries and Point-Counterpoint provide a forum for perspectives in clinical pharmacology and therapeutics in the context of contemporary scientific, political, economic and social issues. State of the Art contributions summarize the latest advances in the science underpinning drug discovery, development, regulation and utilization. CPT highlights issues transforming the practice of clinical pharmacology, including ethics, education and public policy. Bench-to-bedside translation in therapeutics is presented in the context of clinical applications of basic pharmacology, discovery and translational medicine, and drug development.